Assess individuals acquiring acetaminophen and codeine phosphate tablets and any CYP2D6 inhibitor for symptoms and signs that could replicate opioid toxicity and opioid withdrawal when acetaminophen and codeine phosphate tablets are applied in conjunction with inhibitors of CYP2D6.If concomitant utilization of a CYP3A4 inhibitor is essential or if